Vibeke Juliebø
Research Subjects
Vibeke Juliebø has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Leiv Otto Watne
Oslo Delirium Research Group, Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo, Norway
2 shared publications - Torgeir Bruun Wyller
Department of Geriatric Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway
2 shared publications - Anne Cathrine Torbergsen
Institute of Clinical Medicine, University of Oslo, Norway; Department of General Internal Medicine, Oslo University Hospital, Norway
1 shared publication - Bjørn Erik Neerland
Oslo Delirium Research Group, Institute of Clinical Medicine, University of Oslo , Oslo
1 shared publication - Eva Skovlund
Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
1 shared publication - Frede Frihagen
Department of Orthopaedic Surgery, Østfold Hospital Trust, Grålum, Norway
1 shared publication
Latest Publications
- Open Access
- 18 November 2019
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 139 (17)
Where you live determines your treatment
18.11.2019: Leder - Bedre etterlevelse av vedtatte retningslinjer kan utjevne regionale forskjeller i behandlingen av pasienter med hjerteinfarkt.
- 18 November 2019
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 139 (17)
Open AccessWhere you live determines your treatment
18.11.2019: Leder - Bedre etterlevelse av vedtatte retningslinjer kan utjevne regionale forskjeller i behandlingen av pasienter med hjerteinfarkt.
- Open Access
- 6 May 2015
- Published by Springer Nature in BMC Research Notes
- Vol. 8 (1) , 186
Is there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients
Delirium is common, associated with poor outcome, but its pathophysiology remains obscure. The aim of the present study was to study a possible role of monocyte chemoattractant protein-1 (MCP-1) in the development of delirium. A prospective cohort of 19 hip fracture patients (median age 83 years) were screened for delirium daily by validated methods. MCP-1 was measured on arrival and postoperatively. The number of patients with a raise in MCP-1 was statistically significantly higher in the group with delirium in the postoperative phase compared to the no-delirium group (5/6 vs. 1/7, p = .03). MCP-1 might play a role in the development of delirium.
- 6 May 2015
- Published by Springer Nature in BMC Research Notes
- Vol. 8 (1) , 186
Open AccessIs there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients
Delirium is common, associated with poor outcome, but its pathophysiology remains obscure. The aim of the present study was to study a possible role of monocyte chemoattractant protein-1 (MCP-1) in the development of delirium. A prospective cohort of 19 hip fracture patients (median age 83 years) were screened for delirium daily by validated methods. MCP-1 was measured on arrival and postoperatively. The number of patients with a raise in MCP-1 was statistically significantly higher in the group with delirium in the postoperative phase compared to the no-delirium group (5/6 vs. 1/7, p = .03). MCP-1 might play a role in the development of delirium.
- Open Access
- 15 April 2014
- Published by Springer Nature in BMC Medicine
- Vol. 12 (1) , 63
The effect of a pre- and postoperative orthogeriatric service on cognitive function in patients with hip fracture: randomized controlled trial (Oslo Orthogeriatric Trial)
Delirium is a common complication in patients with hip fractures and is associated with an increased risk of subsequent dementia. The aim of this trial was to evaluate the effect of a pre- and postoperative orthogeriatric service on the prevention of delirium and longer-term cognitive decline.
- 15 April 2014
- Published by Springer Nature in BMC Medicine
- Vol. 12 (1) , 63
Open AccessThe effect of a pre- and postoperative orthogeriatric service on cognitive function in patients with hip fracture: randomized controlled trial (Oslo Orthogeriatric Trial)
Delirium is a common complication in patients with hip fractures and is associated with an increased risk of subsequent dementia. The aim of this trial was to evaluate the effect of a pre- and postoperative orthogeriatric service on the prevention of delirium and longer-term cognitive decline.
- Open Access
- 29 November 2012
- Published by Norwegian University of Science and Technology (NTNU) Library in Norsk Epidemiologi
- Vol. 22 (2)
Delirium – a common condition associated with negative outcome in the elderly
Delirium (“acute confusional state”), characterized by an acute decline in attention and cognition, is a common clinical syndrome in elderly patients. The prevalence of delirium increases with age, and is highest among hospitalized older patients. A systematic literature search of MEDLINE, EMBASE, and the Cochrane Library limited to the period 2000-2012 was conducted.The antecedent of delirium is often multifactorial, the development involving a complex interrelationship between a vulnerable patient with predisposing factors and exposure to precipitating events. Important predisposing factors include high age, cognitive impairment, comorbidity, sensory impairment, and low Body Mass Index (BMI). Infections, cardiovascular events, trauma/fracture, surgery, stroke, metabolic abnormalities, and dehydration, are all recognized as precipitating factors.Delirium is associated with negative outcomes like cognitive decline, increased morbidity and mortality, and should be prevented. Prevention and treatment of delirium is multifactorial and multidisiplinary, focusing on the treatment of factors precipitating and maintaining the delirium. No pharmacological treatment has so far demonstrated significant efficacy. The knowledge of risk factors and the underlying pathophysiological mechanisms involved remains scarce, and further research is warranted to explore the mechanisms and thereby develop targeted prevention and treatment strategies.
- 29 November 2012
- Published by Norwegian University of Science and Technology (NTNU) Library in Norsk Epidemiologi
- Vol. 22 (2)
Open AccessDelirium – a common condition associated with negative outcome in the elderly
Delirium (“acute confusional state”), characterized by an acute decline in attention and cognition, is a common clinical syndrome in elderly patients. The prevalence of delirium increases with age, and is highest among hospitalized older patients. A systematic literature search of MEDLINE, EMBASE, and the Cochrane Library limited to the period 2000-2012 was conducted.The antecedent of delirium is often multifactorial, the development involving a complex interrelationship between a vulnerable patient with predisposing factors and exposure to precipitating events. Important predisposing factors include high age, cognitive impairment, comorbidity, sensory impairment, and low Body Mass Index (BMI). Infections, cardiovascular events, trauma/fracture, surgery, stroke, metabolic abnormalities, and dehydration, are all recognized as precipitating factors.Delirium is associated with negative outcomes like cognitive decline, increased morbidity and mortality, and should be prevented. Prevention and treatment of delirium is multifactorial and multidisiplinary, focusing on the treatment of factors precipitating and maintaining the delirium. No pharmacological treatment has so far demonstrated significant efficacy. The knowledge of risk factors and the underlying pathophysiological mechanisms involved remains scarce, and further research is warranted to explore the mechanisms and thereby develop targeted prevention and treatment strategies.